Pharma 4.0 Market Growth Accelerated by adoption of digital technologies
Pharma 4.0 Market |
Pharma 4.0 refers to the digital transformation of
various pharmaceutical processes and business operations with technologies like
artificial intelligence, IoT, blockchain, 3D printing and others. These
technologies enable faster drug discovery and development, improve supply chain
operations, enhance patient engagement and safety. Pharma companies are
increasingly adopting digital tools to streamline clinical trials by enrolling
more volunteers, accelerating drug approvals and better monitoring drug
supplies.
The global
Pharma 4.0 Market is estimated to be valued at US$ 16.75 Bn in 2024 and is
expected to exhibit a CAGR of 18.% over the forecast period 2024 to 2031, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rapid adoption of digital
technologies like AI, IoT and 3D printing in the pharmaceutical industry has
helped accelerate innovation and streamline operations significantly. As pharma
companies digitally transform legacy systems, they are able to develop
personalized drugs faster by leveraging real world data through AI and advanced
analytics. By deploying IoT sensors and 3D printing technologies across
manufacturing units and supply chains, they are improving efficiency as well as
boosting drug production capacity. This widespread digital transformation trend
is expected to drive exponential growth in the Global Pharma 4.0 Market over
the forecast period.
Segment
Analysis
In the global pharma 4.0 market, automation and robot assisted drug discovery
is expected to remain the dominant segment during the forecast period. This is
attributed to increasing adoption of automation in drug discovery processes to
accelerate drug development while also reducing the costs. Automation also
enables processing of large datasets much faster using machine learning and
artificial intelligence algorithms. This has significantly increased the
efficiency and productivity of researchers.
Key Takeaways
Global
Pharma 4.0 Market Size is expected to witness high growth over the
forecast period of 2024 to 2031.
Regional analysis: North America is projected to dominate the global Pharma 4.0
market during the forecast period. This is owing to presence of major
pharmaceutical companies and advanced healthcare infrastructure in the region.
Additionally, increasing R&D investments by market players as well as
government support for development of digital healthcare is also driving the
market in North America. Asia Pacific is expected to witness the highest growth
rate during the forecast period owing rising generic drugs market and
increasing focus of market players in emerging countries of the region.
Key players analysis: Key players operating in the global Pharma 4.0 market are
Oracle, GE Healthcare, Optum, Inc., Honeywell International Inc., IBM
Corporation, Cisco Systems, Inc., Siemens Healthcare GmbH. Oracle offers
cloud-based ERP software solutions Tailored for Pharmaceutical industry to
manage supply chain, finance, HR and manufacturing. GE Healthcare provide a
suite of digital manufacturing and product lifecycle management software for
pharmaceutical industry.
Get More Insights on this Topic- https://www.trendingwebwire.com/pharma-4-0-market-size-share-and-outlook/
Comments
Post a Comment